Adenosine A2a Receptor Antikörper (C-Term, Cytoplasmic Domain)
Kurzübersicht für Adenosine A2a Receptor Antikörper (C-Term, Cytoplasmic Domain) (ABIN1731565)
Target
Alle Adenosine A2a Receptor (ADORA2A) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term, Cytoplasmic Domain
-
Spezifität
- Reacts with human ADORA2A
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Synthetic 20 amino acid peptide from C-terminal cytoplasmic domain of human ADORA2A. Percent identity with other species by BLAST analysis: Human (100%), Gorilla, Gibbon, Monkey, Marmoset (95%), Dog (80%).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
IHC - P (10 μg/mL) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-80 °C
-
Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
-
- Adenosine A2a Receptor (ADORA2A)
-
Andere Bezeichnung
- ADORA2A
-
Hintergrund
- Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.
-
Gen-ID
- 135
-
Pathways
- Neurotrophin Signalübertragung, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints
Target
-